FDA 483 OBSERVATION · #657 OF 1,932 MOST-CITED

Maintain and clean equipment

FDA cited this observation 34 times across 32 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

What this grouping is not

An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.

BY PROGRAM AREA
Biologics34
BY FISCAL YEAR
FY20265
FY20252
FY20241
FY20231
FY20222
FY20202
FY20198
FY20182
FY20173
FY20168

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 0× the rate of the average FDA-cited firm (0.0% vs 7.8%), across 32 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your access…

How FDA worded it — real examples

Failure to maintain equipment used in the collection, processing, compatibility testing, storage and distribution of blood and blood products.

New York Blood Center, Inc. · Fishkill, New York · Biologics · 2026-06-23

Failure to maintain equipment used in the collection and storage of blood and blood products so as to facilitate cleaning and maintenance.

BioLife Plasma Services, L.P. · Glendale, Arizona · Biologics · 2026-06-08

Failure to maintain equipment used in the collection of blood and blood products in a clean and orderly manner and so as to facilitate cleaning and maintenance.

BioLife Plasma Services, L.P. · Las Vegas, Nevada · Biologics · 2026-04-22

Failure to maintain equipment used in the storage and distribution of blood and blood products.

Methodist Hospital Blood Bank · San Antonio, Texas · Biologics · 2026-03-18

Failure to maintain equipment used in the processing of blood and blood products in a clean and orderly manner.

BioLife Plasma Services L.P. · Orem, Utah · Biologics · 2025-12-15

Failure to maintain equipment used in the processing and compatibility testing of blood and blood products in a clean and orderly manner.

LifeSouth Community Blood Centers Inc · Madison, Alabama · Biologics · 2025-09-10

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Biologics industry →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →